GnRH agonist versus GnRH antagonist in in vitro fertilization and embryo transfer (IVF/ET).
about
Optimal usage of the GnRH antagonists: a review of the literatureThe Effects of Chronic Lifelong Activation of the AHR Pathway by Industrial Chemical Pollutants on Female Human ReproductionEvidence of GnRH antagonist escape in obese women.Comparison of GnRH agonist, GnRH antagonist, and GnRH antagonist mild protocol of controlled ovarian hyperstimulation in good prognosis patientsFertility preservation in reproductive-age women facing gonadotoxic treatments.Reassessing the feasibility of the zygote score for predicting embryo viability in IVF/ICSI using the GnRH antagonist protocol compared to the long protocolFixed versus Flexible Gonadotropin Releasing Hormone Antagonist Protocol in Controlled Ovarian Stimulation for Invitro Fertilization in Women with Polycystic Ovary Syndrome.Characterization of 12 GnRH peptide agonists - a kinetic perspectiveComprehensive analysis of genome-wide DNA methylation across human polycystic ovary syndrome ovary granulosa cell.Sequential E2 levels not ovarian maximal diameter estimates were correlated with outcome of cetrotide therapy for management of women at high-risk of ovarian hyperstimulation syndrome: a randomized controlled study.Dynamics of the development of multiple follicles by early versus late hCG administration in ART program.Anti-laminin-1 antibodies in serum and follicular fluid of women with Hashimoto's thyroiditis undergoing in vitro fertilization.What are the best predictors for successful GnRH antagonist protocol in in vitro fertilization (IVF) treatment?In Vitro Fertilization Using Luteinizing Hormone-Releasing Hormone Injections Resulted in Healthy Triplets without Increased Attack Rates in a Hereditary Angioedema Case.Pregnancy outcomes of PCOS overweight/obese patients after controlled ovarian stimulation with the GnRH antagonist protocol and frozen embryo transfer.Endogenous luteinizing hormone concentration and IVF outcome during ovarian stimulation in fixed versus flexible GnRH antagonist protocols: An RCT.
P2860
Q21245566-79EE4ACD-791B-45EE-AA25-A86E8FF213CCQ28550959-7C4FBB11-0B5E-4C58-BB5D-C8A978D8C9CBQ33569055-A0DAA62A-6D32-4994-956C-5A78809A56A9Q35238906-84EF4C29-B3BF-46DB-8B46-46FFF4F1A636Q35934317-18BE1623-9A92-4D58-B299-E169394F36CFQ36267719-2E5723FA-BD7E-4590-B8E6-B052273E3669Q36327270-42C6B468-14DF-4D88-B19F-49F4B9CF1973Q36744172-F68FDABD-3ADF-4048-BCCC-FA0085F2C556Q37317430-B9F3CBB8-25DE-4B9B-864E-8C4DF59D1288Q45035567-F539954C-6C43-4CCA-AF86-5FB4D7FBAFDCQ48536919-33889B9D-5BFE-477C-912B-914C9698C749Q48558828-91F56F09-F2B8-4170-9A2E-D3D97AF1A34FQ48568434-8E12D6D2-8EE3-46CE-92BE-EB7F1667FD90Q52581797-B40D3143-D543-4588-BB30-0801A3E4AE81Q52595629-800B7A47-3820-4BF7-B951-31EAE958A979Q55072129-ADBE4B9A-3E8F-472C-BCB0-0B968BF3999F
P2860
GnRH agonist versus GnRH antagonist in in vitro fertilization and embryo transfer (IVF/ET).
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
GnRH agonist versus GnRH antag ...... and embryo transfer (IVF/ET).
@ast
GnRH agonist versus GnRH antag ...... and embryo transfer (IVF/ET).
@en
type
label
GnRH agonist versus GnRH antag ...... and embryo transfer (IVF/ET).
@ast
GnRH agonist versus GnRH antag ...... and embryo transfer (IVF/ET).
@en
prefLabel
GnRH agonist versus GnRH antag ...... and embryo transfer (IVF/ET).
@ast
GnRH agonist versus GnRH antag ...... and embryo transfer (IVF/ET).
@en
P2093
P2860
P921
P356
P1476
GnRH agonist versus GnRH antag ...... and embryo transfer (IVF/ET).
@en
P2093
Ilaria Totaro
K Jayakrishan
Luigi E Selvaggi
Mariantonietta Panzarino
Raffaella Depalo
P2860
P2888
P356
10.1186/1477-7827-10-26
P577
2012-04-13T00:00:00Z
P5875
P6179
1013706678